Ultragenyx Pharmaceutical Inc. · NASDAQ:RARE
Harris Erik received 28,895 Ultragenyx Pharmaceutical Inc. shares as an award (Form 4)
Traded Apr 16, 2026 · Filed Apr 20, 2026
On Apr 16, 2026, Harris Erik (EVP & Chief Commercial Officer) received 28,895 Ultragenyx Pharmaceutical Inc. shares as an award, leaving 118,410 shares. Filed Apr 20, 2026 (Form 4).
- Awarded
- 28,895 shares
- Holding after
- 118,410 shares
- Trading plan
- No
- Role
- EVP & Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 16, 2026 | Common Stock | Award | 28,895 | 118,410 | Direct |
Source
Related
- Ultragenyx Pharmaceutical Inc.
- Harris Erik
- Ultragenyx Pharmaceutical Inc. shareholders
- Schedule 13G · Madison Avenue Partners, LP · Oct 20, 2026
- Form 4 · Horn Howard · Oct 19, 2026
- Form 4 · Huizenga Theodore Alan · Sep 15, 2026
- Form 4 · Huizenga Theodore Alan · Sep 8, 2026
- Schedule 13G · Rtw Investments, LP · Aug 14, 2026